Prescriptions: Genentech Appeals Avastin Decision
Tuesday, January 18, 2011 - 16:20
in Health & Medicine
The company argues that regulators incorrectly interpreted data on use of the drug to treat breast cancer, and it wants the F.D.A. to rescind its decision to revoke approval.